• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ARCHITECT CORE REAGENT KIT; TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ARCHITECT CORE REAGENT KIT; TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM) Back to Search Results
Catalog Number 06L22-25
Device Problem False Negative Result (1225)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/24/2023
Event Type  malfunction  
Event Description
The customer observed a false nonreactive architect core result for one sample.The following data was provided: 24aug2023: anti-hbcore total result = 0.08 (nonreactive).Anti-hbcore igm result = 11, repeat = 12 (reactive).The physician is questioning the result since the anti-hbcore total result is less than the anti-hbcore m result.The sample was repeated on 13sep2023 and generated the same results.No impact to patient management was reported.
 
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
The customer observed a false nonreactive architect core result for one sample.The following data was provided: 24aug2023: anti-hbcore total result = 0.08 (nonreactive).Anti-hbcore igm result = 11, repeat = 12 (reactive).The physician is questioning the result since the anti-hbcore total result is less than the anti-hbcore m result.The sample was repeated on 13sep2023 and generated the same results.No impact to patient management was reported.
 
Manufacturer Narrative
Section d4 lot # has been updated from 50558be00 to 50607be00.Section g1 has been updated to current contact information.H3 other text : device evaluation still in process.
 
Event Description
The customer observed a false nonreactive architect core result for one sample.The following data was provided: (b)(6) 2023: anti-hbcore total result = 0.08 (nonreactive) anti-hbcore igm result = 11, repeat = 12 (reactive) the physician is questioning the result since the anti-hbcore total result is less than the anti-hbcore m result.The sample was repeated on (b)(6) 2023 and generated the same results.No impact to patient management was reported.
 
Manufacturer Narrative
The complaint investigation for false nonreactive architect core results included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, device history record review, and in house testing.Additionally return sample testing was conducted.Data and information provided by the customer were reviewed and support the complaint issue without indication for any additional issue.A search for similar complaints did not identify an increase in complaint activity.A review of tracking and trending did not identify any trends for the product for the issue.Device history record review did not identify any non-conformances or deviations associated with lot number 50607be00 and the complaint issue.In-house sensitivity testing was completed using an in-house retained kit with complaint lot number 50607be00.All controls met specifications and no false non-reactive results were obtained.The complaint lot detected the same bleeds of the seroconversion panels as reactive, as per the manufacturer data.Labeling was reviewed and found to adequately address the issue under review.The volume of the return sample was not sufficient to execute the complete test protocol as only 80 l were available for testing.Therefore, only the first test of the schedule (alinity s anti-hbc) was performed.Result for sample (b)(6) with alinity s anti-hbc generated a nonreactive result (0.13 s/co), and thus interpretation was in alignment with the customer result.A final disposition for the return sample was not possible due to the test algorithm not being completed.Based on the investigation, no systemic issue or deficiency of the architect core for lot number 50607be00 was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT CORE REAGENT KIT
Type of Device
TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM)
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
Manufacturer (Section G)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM   65205
Manufacturer Contact
nicole jenne
max-planck-ring 2
post market surveillance
wiesbaden 65205
GM   65205
6122582960
MDR Report Key17870991
MDR Text Key324925435
Report Number3002809144-2023-00417
Device Sequence Number1
Product Code LOM
UDI-Device Identifier00380740011123
UDI-Public00380740011123
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P080023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 01/04/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/16/2024
Device Catalogue Number06L22-25
Device Lot Number50607BE00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/14/2023
Initial Date FDA Received10/04/2023
Supplement Dates Manufacturer Received10/18/2023
01/04/2024
Supplement Dates FDA Received11/07/2023
01/04/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/31/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARC I2000SR INST, 03M74-02, (B)(6); ARC I2000SR INST, 03M74-02, (B)(6); ARC I2000SR INST, 03M74-02, (B)(6)
-
-